PMID: 9178838Apr 1, 1997Paper

The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia

Leukemia
P Dreger, N Schmitz

Abstract

Stem cell transplantation (SCT) is increasingly being used for treatment of chronic lymphocytic leukemia (CLL). The present article summarizes available clinical results and discusses important aspects of SCT in patients with CLL including the preferable type of SCT (allogeneic vs autologous), timing of SCT, high-dose regimens, purging, and molecular monitoring of residual disease.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.